CN Patent

CN101166535A — 乳蛋白的皮肤病学应用

Assigned to FrieslandCampina Nederland Holding BV · Expires 2008-04-23 · 18y expired

What this patent protects

本发明提供了治疗痤疮的方法，包括对患有痤疮的人口服给予有效量的包含乳铁蛋白且优选另外包含特异性乳清蛋白的乳清蛋白级分。乳铁蛋白优选为天然牛乳铁蛋白且以10mg－2g乳铁蛋白/患者/天的水平给予乳清蛋白级分。

USPTO Abstract

本发明提供了治疗痤疮的方法，包括对患有痤疮的人口服给予有效量的包含乳铁蛋白且优选另外包含特异性乳清蛋白的乳清蛋白级分。乳铁蛋白优选为天然牛乳铁蛋白且以10mg－2g乳铁蛋白/患者/天的水平给予乳清蛋白级分。

Drugs covered by this patent

oxymetazoline-hydrochloride (OXYMETAZOLINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN101166535A
Jurisdiction: CN
Classification: —
Expires: 2008-04-23
Drug substance claim: No
Drug product claim: No
Assignee: FrieslandCampina Nederland Holding BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.